Literature DB >> 32248018

The protective effect of obeticholic acid on lipopolysaccharide-induced disorder of maternal bile acid metabolism in pregnant mice.

Cheng Zhang1, Yu Gan2, Jin-Wei Lv2, Ming-Qiang Qin3, Wei-Rong Hu2, Zhi-Bing Liu2, Li Ma2, Bing-Dong Song2, Jian Li2, Wei-Ying Jiang3, Jian-Qing Wang4, Hua Wang1, De-Xiang Xu5.   

Abstract

The disorder of bile acid metabolism is a common feature during pregnancy, which leads to adverse birth outcomes and maternal damage effects. However, the cause and therapy about the disorder of bile acid metabolism are still poor. Microbial infection often occurs in pregnant women, which can induce the disorder of bile acid metabolism in adult mice. Here, this study observed the acute effect of lipopolysaccharide (LPS) on maternal bile acid of pregnant mice at gestational day 17 and the protective effect of obeticholic acid (OCA) pretreatment, a potent agonist of bile acid receptor farnesoid X receptor (FXR). The results showed LPS significantly increased the level of maternal serum and disordered bile acids components of maternal serum and liver, which were ameliorated by OCA pretreatment with obviously reducing the contents of CA, TCA, DCA, TCDCA, CDCA, GCA and TDCA in maternal serum and DCA, TCA, TDCA, TUDCA, CDCA and TCDCA in maternal liver. Furthermore, we investigated the effects of OCA on LPS-disrupted bile acid metabolism in maternal liver. LPS disrupted maternal bile acid profile by decreasing transport and metabolism with hepatic tight junctions of bile acid in pregnant mice. OCA obviously increased the protein level of nuclear FXR and regulated its target genes involving in the metabolism of bile acid, which was characterized by the lower expression of bile acid synthase CYP7A1, the higher expression of CYP3A and the higher mRNA level of transporter Mdr1a/b. This study provided the evidences that LPS disrupted bile acid metabolism in the late stage of pregnant mice and OCA pretreatment played the protective role on it by activating FXR.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bile acid disorder; Farnesoid X receptor; Lipopolysaccharide; Obeticholic acid; Pregnancy

Mesh:

Substances:

Year:  2020        PMID: 32248018     DOI: 10.1016/j.intimp.2020.106442

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  4 in total

1.  Based on Network Pharmacology and RNA Sequencing Techniques to Explore the Molecular Mechanism of Huatan Jiangzhuo Decoction for Treating Hyperlipidemia.

Authors:  Xiaowen Zhou; Zhenqian Yan; Yaxin Wang; Qi Ren; Xiaoqi Liu; Ge Fang; Bin Wang; Xiantao Li
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-09       Impact factor: 2.629

2.  Porphyromonas gingivalis Administration Induces Gestational Obesity, Alters Gene Expression in the Liver and Brown Adipose Tissue in Pregnant Mice, and Causes Underweight in Fetuses.

Authors:  Sumiko Yoshida; Masahiro Hatasa; Yujin Ohsugi; Yosuke Tsuchiya; Anhao Liu; Hiromi Niimi; Kazuki Morita; Tsuyoshi Shimohira; Naoki Sasaki; Shogo Maekawa; Takahiko Shiba; Tomomitsu Hirota; Tokuju Okano; Asuka Hirose; Rinko Ibi; Kanako Noritake; Yuki Tomiga; Hiroshi Nitta; Toshihiko Suzuki; Hirokazu Takahashi; Naoyuki Miyasaka; Takanori Iwata; Sayaka Katagiri
Journal:  Front Cell Infect Microbiol       Date:  2022-01-13       Impact factor: 5.293

3.  Effects of Intestinal FXR-Related Molecules on Intestinal Mucosal Barriers in Biliary Tract Obstruction.

Authors:  Meng Yan; Li Hou; Yaoyao Cai; Hanfei Wang; Yujun Ma; Qiming Geng; Weiwei Jiang; Weibing Tang
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

4.  Impact on Bile Acid Concentrations by Alveolar Echinococcosis and Treatment with Albendazole in Mice.

Authors:  Cristina Gómez; Fadi Jebbawi; Michael Weingartner; Junhua Wang; Simon Stücheli; Bruno Stieger; Bruno Gottstein; Guido Beldi; Britta Lundström-Stadelmann; Alex Odermatt
Journal:  Metabolites       Date:  2021-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.